HUP0200498A2 - Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutyl amine for treatment of hiatial hernia - Google Patents

Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutyl amine for treatment of hiatial hernia

Info

Publication number
HUP0200498A2
HUP0200498A2 HU0200498A HUP0200498A HUP0200498A2 HU P0200498 A2 HUP0200498 A2 HU P0200498A2 HU 0200498 A HU0200498 A HU 0200498A HU P0200498 A HUP0200498 A HU P0200498A HU P0200498 A2 HUP0200498 A2 HU P0200498A2
Authority
HU
Hungary
Prior art keywords
cyclobutyl
dimethyl
treatment
methylbutyl amine
hiatial
Prior art date
Application number
HU0200498A
Other languages
Hungarian (hu)
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of HUP0200498A2 publication Critical patent/HUP0200498A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0200498A 1999-03-19 2000-03-17 Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutyl amine for treatment of hiatial hernia HUP0200498A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12511699P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
HUP0200498A2 true HUP0200498A2 (en) 2002-08-28

Family

ID=22418261

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200498A HUP0200498A2 (en) 1999-03-19 2000-03-17 Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutyl amine for treatment of hiatial hernia

Country Status (20)

Country Link
EP (1) EP1169028A1 (en)
JP (1) JP2002539249A (en)
KR (1) KR20030006909A (en)
CN (1) CN1376061A (en)
AU (1) AU3894400A (en)
BG (1) BG106000A (en)
BR (1) BR0009160A (en)
CA (1) CA2367035A1 (en)
CZ (1) CZ20013279A3 (en)
HK (1) HK1044703A1 (en)
HU (1) HUP0200498A2 (en)
IL (1) IL145242A0 (en)
MX (1) MXPA01009463A (en)
NO (1) NO20014476L (en)
NZ (1) NZ514013A (en)
PL (1) PL351081A1 (en)
SK (1) SK13392001A3 (en)
TR (1) TR200102700T2 (en)
WO (1) WO2000056307A1 (en)
ZA (1) ZA200107679B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006833B (en) * 2012-12-31 2014-02-12 代凤玲 Medicine for hiatus hernia postoperative rehabilitation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver

Also Published As

Publication number Publication date
BG106000A (en) 2002-06-28
EP1169028A1 (en) 2002-01-09
TR200102700T2 (en) 2002-04-22
NZ514013A (en) 2001-09-28
IL145242A0 (en) 2002-06-30
HK1044703A1 (en) 2002-11-01
MXPA01009463A (en) 2004-03-19
WO2000056307A1 (en) 2000-09-28
CN1376061A (en) 2002-10-23
NO20014476L (en) 2001-10-29
NO20014476D0 (en) 2001-09-14
JP2002539249A (en) 2002-11-19
KR20030006909A (en) 2003-01-23
CA2367035A1 (en) 2000-09-28
ZA200107679B (en) 2003-06-18
CZ20013279A3 (en) 2002-07-17
SK13392001A3 (en) 2002-04-04
BR0009160A (en) 2002-01-29
AU3894400A (en) 2000-10-09
PL351081A1 (en) 2003-03-10

Similar Documents

Publication Publication Date Title
PL369326A1 (en) Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
HK1044528A1 (en) Monoamine reuptake inhibitors for treatment of cnsdisorders.
IL147790A0 (en) Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
HUP0200406A2 (en) Method for the reductive amination of polysaccharides
ZA200203254B (en) Polymorphic forms of sertraline hydrochloride.
GB2388799B (en) A process for preparing a catalyst, the catalyst and a use of the catalyst
HUP0501066A2 (en) Process for preparing 4-aminodiphenylamine
IL151838A0 (en) Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n- (4-methoxyphenyl)-3-chloropropionamide
PL368203A1 (en) Supported catalyst for hydrogenation of nitroaromatics
HUP0303496A3 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
HUP0200501A3 (en) Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for treating sleep apnoea
WO2000056315A8 (en) Treatment of pain
IL162171A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
IL161989A0 (en) Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
HK1064609A1 (en) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino alkyl -acid derivatives for the treatment of pain
HUP0200498A2 (en) Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutyl amine for treatment of hiatial hernia
AU5404500A (en) Reductive amination of aldehydes
MXPA01009461A (en) Treatment of osteoarthritis.
IL158585A0 (en) Processes and intermediates for preparing benzyl epoxides
MXPA01009468A (en) Treatment of pulmonary hypertension.
HUP0200497A2 (en) Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for treatment of certain cancers associated with weight gain
GB0127100D0 (en) Elastic support band
EP1439185A4 (en) Stabilization of amrubicin hydrochloride
IL162125A (en) Use of n-(indolcarbonyl)- piperazine derivatives for the preparation of medicaments for the treatment of obesity